Highlight
– Proteinuria levels in women undergoing expectant management for preterm pre-eclampsia strongly correlate with pregnancy latency duration.
– Higher proteinuria is associated with increased risk of adverse maternal outcomes but does not predict perinatal adverse outcomes.
– Proteinuria performs comparably to angiogenic biomarkers (sFlt-1/PIGF ratio) in predicting pregnancy latency and maternal complications.
– Proteinuria measurement may serve as a practical prognostic tool to guide clinical decision-making in preterm pre-eclampsia.
